<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:03:54Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5325358" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5325358</identifier><datestamp>2017-03-23</datestamp><setSpec>oncotarget</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Oncotarget</journal-id>
      <journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id>
      <journal-id journal-id-type="publisher-id">Oncotarget</journal-id>
      <journal-id journal-id-type="publisher-id">ImpactJ</journal-id>
      <journal-title-group>
        <journal-title>Oncotarget</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1949-2553</issn>
      <publisher>
        <publisher-name>Impact Journals LLC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5325358</article-id>
      <article-id pub-id-type="pmcid">PMC5325358</article-id>
      <article-id pub-id-type="pmc-uid">5325358</article-id>
      <article-id pub-id-type="pmid">27556504</article-id>
      <article-id pub-id-type="pmid">27556504</article-id>
      <article-id pub-id-type="publisher-id">11438</article-id>
      <article-id pub-id-type="doi">10.18632/oncotarget.11438</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>FAM65B controls the proliferation of transformed and primary T cells</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Froehlich</surname>
            <given-names>Jeanne</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="A3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Versapuech</surname>
            <given-names>Margaux</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="A3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Megrelis</surname>
            <given-names>Laura</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="A3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Largeteau</surname>
            <given-names>Quitterie</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="A3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meunier</surname>
            <given-names>Sylvain</given-names>
          </name>
          <xref ref-type="aff" rid="A4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tanchot</surname>
            <given-names>Corinne</given-names>
          </name>
          <xref ref-type="aff" rid="A4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bismuth</surname>
            <given-names>Georges</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="A3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Delon</surname>
            <given-names>JÃ©rÃ´me</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="A3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Mangeney</surname>
            <given-names>Marianne</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="A3">
            <sup>3</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><sup>1</sup> Inserm, Institut Cochin, Paris, France</aff>
      <aff id="A2"><sup>2</sup> Cnrs, Paris, France</aff>
      <aff id="A3"><sup>3</sup> UniversitÃ© Paris Descartes, Sorbonne Paris CitÃ©, Paris, France</aff>
      <aff id="A4"><sup>4</sup> Inserm, PARCC, UniversitÃ© Paris Descartes, Sorbonne Paris CitÃ©, Paris, France</aff>
      <author-notes>
        <corresp id="cor1"><bold>Correspondence to:</bold> Marianne Mangeney, <email>marianne.mangeney@inserm.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <day>27</day>
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <volume>7</volume>
      <issue>39</issue>
      <fpage>63215</fpage>
      <lpage>63225</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>8</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: Â© 2016 Froehlich et al.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Cell quiescence is controlled by regulated genome-encoded programs that actively express genes which are often down-regulated or inactivated in transformed cells. Among them is FoxO1, a transcription factor that imposes quiescence in several cell types, including T lymphocytes. In these cells, the FAM65B encoding gene is a major target of FOXO1. Here, we show that forced expression of FAM65B in transformed cells blocks their mitosis because of a defect of the mitotic spindle, leading to G2 cell cycle arrest and apoptosis. Upon cell proliferation arrest, FAM65B is engaged in a complex containing two proteins well known to be involved in cell proliferation i.e. the HDAC6 deacetylase and the 14.3.3 scaffolding protein. In primary T cells, FAM65B is down-regulated upon T cell receptor engagement, and maintaining its expression blocks their proliferation, establishing that the decrease of FAM65B expression is required for proliferation. Conversely, inhibiting FAM65B expression in naive T lymphocytes decreases their activation threshold. These results identify FAM65B as a potential new target for controlling proliferation of both transformed and normal cells.</p>
      </abstract>
      <kwd-group>
        <kwd>cell proliferation</kwd>
        <kwd>cell cycle</kwd>
        <kwd>signaling</kwd>
        <kwd>T lymphocytes</kwd>
        <kwd>leukemia</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>INTRODUCTION</title>
      <p>Before encountering foreign antigens, naive T lymphocytes do not proliferate. It was initially assumed that this âdefaultâ state reflected the absence of activating signals [<xref rid="R1" ref-type="bibr">1</xref>]. It is now known that the steady-state maintenance of naive T cells is an active state and depends on a combination of signals from the IL-7 receptor and the T cell antigen receptor (TCR) triggered by major histocompatibility complex (MHC) molecules loaded with self-peptides [<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R3" ref-type="bibr">3</xref>]. Paradoxically, the same signals lead to a loss of quiescence of naive T cells in some situations such as lymphopenia, and result in entry into the cell cycle (lymphopenia-induced proliferation) and acquisition of memory-like markers [<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R3" ref-type="bibr">3</xref>]. Therefore, naive T cells are somehow restrained in proliferation, but this restraint can be alleviated by external cues. The molecular mechanisms underlying such restraint have proven elusive.</p>
      <p>The forkhead box O1 (FoxO1) transcription factor is involved in the maintenance of the quiescence state of T cells [<xref rid="R4" ref-type="bibr">4</xref>]. The FoxO family is the mammalian orthologue of the <italic>c-elegans</italic> protein DAF16, and has an evolutionarily conserved function in the adaptation of proliferation-to-nutrient availability [<xref rid="R5" ref-type="bibr">5</xref>]. In quiescent T cells, FoxO1 is nuclear, and binds DNA. This DNA binding drives the transcription of several genes that encode proteins involved in cell mobility, cell survival and quiescence. Upon TCR stimulation, FOXO1 is phosphorylated by Akt kinase under the control of the phospho-inositide 3 kinase (PI3K) pathway, leading to its nuclear exclusion and an arrest of its transcriptional activity [<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref>]. Conditional deletion of Foxo1 in mouse T cells results in spontaneous activation of T cells with an activated-memory phenotype [<xref rid="R8" ref-type="bibr">8</xref>].</p>
      <p>We previously identified family with sequence similarity 65, member B (FAM65B; previously known as C6ORF32, KIAA0386 or PL48), as a transcriptional target of FOXO1 in T cells [<xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R9" ref-type="bibr">9</xref>]. Two main isoforms of FAM65B proteins are expressed in T cells and have been functionally characterized as an atypical inhibitor of the small G protein RhoA [<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref>]. FAM65B has also been described to induce neurite-like outgrowths in HEK293 and C2C12 cells probably through an action on microtubules [<xref rid="R11" ref-type="bibr">11</xref>]. This step appears to be involved in myoblast fusion and differentiation [<xref rid="R12" ref-type="bibr">12</xref>]. More recently, the protein has been shown to be a component of hair cell stereocilia, an actin-rich structure required for hearing [<xref rid="R13" ref-type="bibr">13</xref>]. The FAM65B protein does not seem to be endowed with intrinsic enzymatic properties. Instead, its functional effect in cell mobility seems to rely on its interaction with the small G protein RhoA [<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref>], whereas its role in myoblast differentiation is dependent on its interaction with a complex containing the histone deacetylase HDAC6 and 14.3.3 proteins [<xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R12" ref-type="bibr">12</xref>]. The 14.3.3 proteins are a family of regulatory signaling molecules that interact with other proteins in a phosphorylation-dependent manner and function as adapter or scaffold proteins in signal transduction pathways [<xref rid="R14" ref-type="bibr">14</xref>]. Although 14.3.3 proteins act in cell signaling, cell cycle control, and apoptotic cell death, a large group of 14.3.3 -binding partners have been described to regulate cytoskeleton architecture [<xref rid="R15" ref-type="bibr">15</xref>].</p>
      <p>We now report that FAM65B can act as a molecular switch controlling quiescence of normal T cells and proliferation of malignant cell lines. Analyzing the mechanism responsible for this effect, we show that proliferating cells are blocked in mitosis due to a defect of the mitotic spindle triggered by FAM65B overexpression. We also demonstrate at the molecular level that FAM65B forms a molecular complex with HDAC6 and 14.3.3, and that this tripartite complex is required for proliferation arrest. We also show that quiescent T lymphocytes express high levels of FAM65B and that a rapid down-regulation of the molecule is necessary to enable T cells to divide in response to TCR engagement. Accordingly, we also show that FAM65B cellular levels set the activation threshold of T cells required to start a substantial proliferation.</p>
    </sec>
    <sec id="s2">
      <title>RESULTS</title>
      <sec id="s2_1">
        <title>FAM65B inhibits the proliferation of human leukemic T cells</title>
        <p>FAM65B is transcriptionally controlled by FOXO1 [<xref rid="R9" ref-type="bibr">9</xref>]. In the Jurkat leukemic T cell line, where the PI3K pathway is constitutively active, FOXO1 is permanently shut-down and so degraded [<xref rid="R16" ref-type="bibr">16</xref>] (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S1A</xref>, lane 2), and the two isoforms of FAM65B are not expressed ([<xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R9" ref-type="bibr">9</xref>], <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S1B</xref>, lane 1). We therefore used these cells to follow how FAM65B re-expression could affect their growth. Cells were transfected with expression constructs coding for GFP alone as a control, or for FAM65B isoform 2 fused to GFP. Having confirmed that FAM65B re-expression did not alter FOXO1 expression level (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S1A</xref>, lane 2 and 3), we monitored the proliferation by counting the total viable cell number daily, and quantifying the percentage of GFP<sup>+</sup> cells by flow cytometry. In contrast to control cells, the number of FAM65B expressing cells did not increase over time (Figure <xref ref-type="fig" rid="F1">1A</xref>). The same effect was observed when FAM65B isoform 1 fused to GFP was expressed (data not shown). Analysis of the cell cycle demonstrated that FAM65B expression results in a G2/M accumulation after 3 days of culture, with 47 Â± 7% (mean Â± SD) of FAM65B positive <italic>vs</italic> 22 Â± 1.4% of control cells in G2/M phase (Figure <xref ref-type="fig" rid="F1">1B and 1C</xref>). In addition, annexin V labelling revealed that the percentage of dying cells was significantly increased by FAM65B (Figure <xref ref-type="fig" rid="F1">1D</xref>).</p>
        <fig id="F1" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <title>FAM65B expression inhibits cell proliferation by perturbing mitosis stage</title>
            <p>(<bold>A</bold>) Jurkat cells were transfected either with GFP or FAM65B fused with GFP expression vectors and their proliferation was measured by counting the total viable cell number at the indicated time points. (<bold>B</bold>) The cell cycle profile was evaluated by flow cytometry three days after transfection. (<bold>C</bold>) The proportion of transfected Jurkat cells in G2/M phase was estimated daily by flow cytometry. (<bold>D</bold>) The proportion of annexin V-labeled cells was measured daily by flow cytometry. Results are shown as means Â± SD of at least three individual experiments. Statistical analysis: Paired two-tailed Student's <italic>t</italic>-test.</p>
          </caption>
          <graphic xlink:href="oncotarget-07-63215-g001"/>
        </fig>
      </sec>
      <sec id="s2_2">
        <title>FAM65B is a mitotic inhibitor that alters the formation of the mitotic spindle</title>
        <p>In order to study in detail the mechanism of this FAM65B-induced growth arrest, we used the classic model of adherent HeLa cancer cell line. HeLa cells, as all cell lines that we have tested including HEK293, NIH3T3 and CEM cells, do not express FAM65B (data not shown). We first show that, as observed in Jurkat cells, FAM65B expression led to an increase of HeLa cells in G2/M phase (55% vs 29% in control cells; Figure <xref ref-type="fig" rid="F2">2A</xref>). Next, in order to analyze how FAM65B might disturb the mitotic process, we co-transfected HeLa cells with vectors coding for GFP alone or FAM65B-GFP, and histone H2B-mCherry, to monitor the dynamics of DNA reorganization during mitosis. Whereas cells transfected with GFP alone completed mitosis in 43 Â± 9 min, the time required for mitosis of FAM65B-expressing cells was more variable and longer (94 Â± 65 min, Figure <xref ref-type="fig" rid="F2">2B and 2D</xref>). Chromosomes in the control cell were perfectly aligned on the metaphase plate 16 Â± 5 min after initiation of cell division, as determined by cell rounding (Figure <xref ref-type="fig" rid="F2">2C and 2D</xref>). In contrast, FAM65B-expressing cells were not able to align chromosomes correctly, leading to abnormal anaphases with frequent lagging chromatids after more than 20 min for 37% of the cells, and more than 40 min for 14% of the cells (Figure <xref ref-type="fig" rid="F2">2C and 2D</xref>).</p>
        <fig id="F2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <title>FAM65B expression disrupts the formation of the mitotic spindle, resulting in mitotic failure</title>
            <p>(<bold>A</bold>) The cell cycle of HeLa cells transfected with GFP alone or FAM65B fused with GFP expression vectors was analyzed by flow cytometry two days after transfection. Results are representative of three experiments. The time required for each HeLa cell co-transfected with Histone H2B-mCherry and GFP (<italic>n</italic> = 22) or FAM65B-GFP (<italic>n</italic> = 27) expressing vectors to complete a division (<bold>B</bold> and <bold>D</bold>) or to align chromosomes (<bold>C</bold>) was evaluated by time-lapse microscopy. Statistical analysis: Paired two-tailed Student's <italic>t</italic>-test. (<bold>E</bold>) HeLa cells were co-transfected with Î±-tubulin-GFP and m-Cherry (<italic>n</italic> = 14) or FAM65B-mCherry (<italic>n</italic> = 20), and their capacity to form a mitotic spindle was followed by time-lapse microscopy.</p>
          </caption>
          <graphic xlink:href="oncotarget-07-63215-g002"/>
        </fig>
        <p>Chromosome movements during mitosis rely upon a complex macromolecular machinery known as the mitotic spindle. The spindle has three principal components, centrosomes, microtubules composed of Î±-tubulin, and chromosomes [<xref rid="R17" ref-type="bibr">17</xref>]. Since FAM65B is described as regulating the elongation of microtubules [<xref rid="R18" ref-type="bibr">18</xref>], we supposed that FAM65B expression might perturb the formation of the mitotic spindle. To test this hypothesis, we co-transfected HeLa cells with vectors coding for GFP alone or FAM65B-GFP, and Î±-tubulin-mCherry, to follow the microtubule network during mitosis. We observed that, whereas cells transfected with GFP alone were able to form a mitotic spindle, FAM65B-expressing cells presented an aberrant tubulin network with an absence of clear mitotic spindle (Figure <xref ref-type="fig" rid="F2">2E</xref>). These results show that FAM65B expression disturbs the formation of the mitotic spindle, resulting in mitotic failure.</p>
      </sec>
      <sec id="s2_3">
        <title>The FAM65B/HDAC6/14.3.3 tripartite complex is required for proliferation arrest</title>
        <p>We then examined the implication of known targets of FAM65B in the molecular mechanism of growth arrest. We have previously shown that FAM65B binds directly and inhibits RhoA [<xref rid="R9" ref-type="bibr">9</xref>], a protein that has been involved in cytokinesis [<xref rid="R19" ref-type="bibr">19</xref>]. We hypothesized that the effect of FAM65B on proliferation could be due to this interaction. Therefore, we constructed a plasmid coding for a mutant version of FAM65B unable to bind RhoA (RL151-152AA, [<xref rid="R10" ref-type="bibr">10</xref>] and Figure <xref ref-type="fig" rid="F3">3A</xref>). Upon transfection, this mutant was still able to inhibit proliferation of Jurkat T cells as efficiently as the wild type FAM65B protein, thus showing that the anti-proliferative activity of FAM65B was not due to its RhoA inhibitory activity (Figure <xref ref-type="fig" rid="F3">3B</xref>).</p>
        <fig id="F3" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <title>The anti-proliferative property of FAM65B results from its capacity to interfere with HDAC6 and 14.3.3</title>
            <p>(<bold>A</bold>) Lysates from HEK293T cells transfected with FAM65B-GFP or FAM65B RL151-152AA-GFP mutant were subjected to a pull-down assay using beads bearing GST-RhoA. (<bold>B</bold>) The proliferation of transfected Jurkat cells with GFP alone (Control: CT) and wild type or mutant RL151-152AA forms of FAM65B expression vectors was measured by daily counting the number of viable cells. Results are shown as means Â± SD of at least three individual experiments. (<bold>C</bold>) HEK293T cells were transfected with pEF-Myc vector expressing either no protein (Control: CT), FAM65B or its mutant S(x5)A form fused to GFP. Whole cell lysates (WCL) and anti-Myc immunoprecipitates were analyzed by immunoblotting. (<bold>D</bold>) The proliferation of transfected Jurkat cells with either GFP alone (Control: CT), wild type or mutant S(x5)A of FAM65B expression vectors was measured by counting daily the number of viable cells. Results are shown as means Â± SD of at least three individual experiments. (<bold>E</bold>) The proliferation of Jurkat cells co-transfected with mCherry or FAM65B-mCherry and GFP or HDAC6-GFP was measured by counting the number of viable cells every day. Results are shown as means Â± SD of at least three individual experiments. (<bold>F</bold>) HEK293T cells were co-transfected with HDAC6-GFP, 14.3.3-HA and pEF-Myc vector expressing either FAM65B or its mutant S(x5)A form. Whole cell lysates and anti-Myc immunoprecipitates were analyzed by immunoblotting.</p>
          </caption>
          <graphic xlink:href="oncotarget-07-63215-g003"/>
        </fig>
        <p>It has been shown that the phosphorylated form of FAM65B can interact with 14.3.3, a family of proteins that bind to phospho-Serine and phospho-Threonine residues and play important roles in various processes, including in coordinating cell cycle progression [<xref rid="R14" ref-type="bibr">14</xref>]. As FAM65B has been described as a phosphorylated protein in neutrophils [<xref rid="R10" ref-type="bibr">10</xref>], we examined its phosphorylation status in Jurkat T cells by treating whole cell extracts with Î»-phosphatase. We observed a decrease of the apparent molecular weight of the protein (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S1B</xref>), suggesting that FAM65B is also phosphorylated in these cells. A previous report has shown that a mutant form of FAM65B with serine residues mutated to alanine at positions 21, 37, 341, 523, and 535, (hereafter called FAM65B S(x5)A) did not bind 14.3.3 anymore [<xref rid="R10" ref-type="bibr">10</xref>], see also Figure <xref ref-type="fig" rid="F3">3C</xref>). We therefore investigated whether this mutant could have an anti-proliferative effect. We observed that the S(x5)A phosphorylation mutant of FAM65B lost its capacity to inhibit the proliferation of Jurkat cells (Figure <xref ref-type="fig" rid="F3">3D</xref>). Therefore, the phosphorylation of FAM65B and its interaction with 14.3.3 is required for its anti-proliferative activity.</p>
        <p>It has been stated that (i) 14.3.3 is a molecular partner of HDAC6 [<xref rid="R20" ref-type="bibr">20</xref>], (ii) inhibition of the deacetylase activity of HDAC6 leads to inhibition of cell proliferation, and (iii) FAM65B inhibits the deacetylase activity of HDAC6 [<xref rid="R12" ref-type="bibr">12</xref>]. We therefore speculated that the anti-proliferative effect of FAM65B might rely on its capacity to inhibit HDAC6 through its interaction with 14.3.3. To test this hypothesis, we first tried to reverse the anti-proliferative effect of FAM65B by an excess of HDAC6 in FAM65B-arrested Jurkat cells. The results showed that an excess of HDAC6 was able to partially override the FAM65B-induced proliferation arrest (Figure <xref ref-type="fig" rid="F3">3E</xref>). Conversely, inhibition of HDAC6 with a pharmacological inhibitor dose-dependently inhibited the growth of Jurkat cells and induced a marked G2/M arrest, mimicking the effect of FAM65B (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S2A</xref>), in a similar fashion to what is normally observed with etoposide (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S3</xref>). We next assessed the interaction between FAM65B, 14.3.3, and HDAC6, and the role of FAM65B phosphorylation in these interactions. To do this, we co-transfected HDAC6 and 14.3.3 with wild type or S(x5)A form of FAM65B. Whereas HDAC6 and 14.3.3 co-immunoprecipitate with the wild-type form of FAM65B (Figure <xref ref-type="fig" rid="F3">3F</xref>, lane 1), the mutated form of FAM65B was unable to interact with these two partners (Figure <xref ref-type="fig" rid="F3">3F</xref>, lane 2). These results suggest that the anti-proliferative property of FAM65B results from the capacity of its phosphorylated form to interact with HDAC6 and 14.3.3.</p>
      </sec>
      <sec id="s2_4">
        <title>FAM65B controls T cell proliferation upon TCR stimulation</title>
        <p>We next analysed the consequences of the regulation of cell division by FAM65B upon physiological T cell activation. We first followed the expression level of FAM65B in T cells upon TCR triggering to see whether it was subject to variations after stimulation. FAM65B expression was quantified at the transcript and protein levels, following <italic>in vitro</italic> stimulation of primary human T lymphocytes with anti-CD3 and -CD28 coated beads. FAM65B transcripts decreased quickly upon TCR stimulation (Figure <xref ref-type="fig" rid="F4">4A</xref>), in line with a general and early block in FOXO1-mediated transcription upon antigen recognition [<xref rid="R6" ref-type="bibr">6</xref>]. Both FAM65B isoforms show a simultaneous loss, which was complete 24 hours after the onset of stimulation (Figure <xref ref-type="fig" rid="F4">4B</xref>). This observation is not related to cell culture as the level of FAM65B is constant in non-stimulated cells. To reveal the functional importance of this decrease, we next followed the consequences of maintaining FAM65B expression during activation. Primary human T cells were transfected with a plasmid coding for FAM65B-GFP (or GFP alone as a control), activated with anti-CD3 and -CD28 coated beads, and cell proliferation was monitored by analyzing cell trace violet (CTV) dilution of GFP<sup>+</sup> cells. We observed that expression of FAM65B totally inhibits the proliferation induced by TCR engagement (Figure <xref ref-type="fig" rid="F4">4C</xref>). ERK phosphorylation (Figure <xref ref-type="fig" rid="F4">4D</xref>) and CD69 expression (Figure <xref ref-type="fig" rid="F4">4E</xref>) upon TCR stimulation was similarly induced in both conditions, excluding any major defect in early TCR signaling upon FAM65B expression. Again, we also observed that addition of an HDAC6 inhibitor on primary T cells stimulated with anti-CD3 and -CD28 coated-beads has the same effects than FAM65B, leading to an inhibition of proliferation with no cell death (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S2B</xref>). With a complementary approach, we used RNA interference (RNAi) to study the consequences of decreasing FAM65B expression prior to TCR stimulation of primary human peripheral blood T cells (Figure <xref ref-type="fig" rid="F5">5A</xref>). We observed that FAM65B-depleted cells proliferated more than control cells (Figure <xref ref-type="fig" rid="F5">5B</xref>).</p>
        <fig id="F4" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <title>FAM65B expression is inversely correlated with the proliferative potential of activated T cells</title>
            <p>Primary human T cells were stimulated <italic>in vitro</italic> for several hours using anti-CD3 and -CD28 coated-beads. FAM65B expression was quantified at both the transcript (<bold>A</bold>) and the protein (<bold>B</bold>) levels. (<bold>C</bold>) Primary human T cells were transfected with GFP (Control: CT) or FAM65B-GFP expression vector then stained with Cell Trace Violet (CTV) and stimulated <italic>in vitro</italic> as described in (A) for 4 days. In the histograms, the grey lines correspond to the GFP<sup>+</sup> cells and the black lines to the GFP<sup>â</sup> cells. Note that in CT conditions, GFP<sup>+</sup> cells proliferate slightly less efficiently than GFP<sup>â</sup> cells. This is likely to be an effect of the transfection <italic>per se</italic>. (<bold>D</bold>) ERK phosphorylation and (<bold>E</bold>) CD69 expression of transfected cells stimulated or not with anti-CD3 and âCD28 was analyzed by flow cytometry after 3 minutes and 8 hours of culture, respectively.</p>
          </caption>
          <graphic xlink:href="oncotarget-07-63215-g004"/>
        </fig>
        <fig id="F5" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <title>FAM65B expression is inversely correlated with the T cells activation threshold</title>
            <p>(<bold>A</bold>) The efficiency of FAM65B knock-down in human primary T cells was checked by immunoblotting with anti-FAM65B and anti-Î±-tubulin as a loading control. (<bold>B</bold>) Human primary T cells were transfected with control (siCT) or FAM65B (siFAM65B) siRNA, then stained with CTV and stimulated <italic>in vitro</italic> for 3 days using anti-CD3 and -CD28 coated-beads. The proliferation of transfected cells was analyzed by flow cytometry after 3 days of stimulation. The percentage of cells exhibiting 0, 1, 2, 3, 4 divisions or the addition of them (total) is quantified as the mean Â± SD obtained from four donors. (<bold>C</bold>) Naive (CD45RA+) or activated/memory (CD45RO+) populations were purified from peripheral blood T cells. FAM65B expression was then analyzed by immunoblotting. (<bold>D</bold>) Primary human CD45RA<sup>+</sup> T cells transfected with siFAM65B or siCT were stained with CTV and stimulated <italic>in vitro</italic> using variable doses of anti-CD3 and anti-CD28 -coated beads. The proliferation of the transfected cells was analyzed by flow cytometry after 3 days of stimulation. Results are representative of at least three individual experiments</p>
          </caption>
          <graphic xlink:href="oncotarget-07-63215-g005"/>
        </fig>
        <p>Primary peripheral T cells have a heterogeneous capacity to proliferate based on CD45RA expression ([<xref rid="R21" ref-type="bibr">21</xref>] and <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S4</xref>). We purified naive CD45RA+ (high activation threshold) and CD45RO+ (low activation threshold) populations from peripheral blood T cells, and sought to determine whether the lower activation threshold of CD45RO+ T cells was associated with decreased FAM65B expression levels. Indeed, our results show that these cells express a lower level of FAM65B than naive CD45RA+ cells (Figure <xref ref-type="fig" rid="F5">5C</xref>).</p>
        <p>We then studied the proliferation of CD45RA+ cells upon activation with increasing doses of anti-CD3 and -CD28 coated-beads after FAM65B depletion. For all experiments, the depletion of FAM65B was verified by intracellular staining and flow cytometry analysis (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S5</xref>). In the absence of stimulation, no proliferation was observed. However, FAM65B-depleted cells were induced to proliferate at sub-optimal doses of activators that induced only marginal proliferation of control T lymphocytes expressing FAM65B (Figure <xref ref-type="fig" rid="F5">5D</xref>). These results show that there is an inverse correlation between the cellular levels of FAM65B and the capacity of human primary T cells to proliferate in response to an activation signal. They ultimately suggest that the decrease of FAM65B expression is a pre-requisite for T-cell proliferation.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>DISCUSSION</title>
      <p>We show here that FAM65B, a major transcriptional target of FOXO1, known as a quiescence factor, inhibits the proliferation of transformed cell lines through perturbation of mitosis. Our data suggest that this effect is linked to the capacity of FAM65B to inhibit the HDAC6/14.3.3 cell proliferation control pathway. In primary T cells, we observed that FAM65B expression regulates cell proliferation. Finally, our results indicate that the level of expression of FAM65B might also set the activation threshold of sub-populations of T cells.</p>
      <p>Our work establishes that inhibition of FAM65B expression is required for cell proliferation as its ectopic expression in proliferating cells induces cell cycle arrest and death. Therefore, FAM65B could be considered as a <italic>bona fide</italic> quiescence factor. It was initially thought that cells spontaneously become quiescent. It is now believed that quiescence is a cellular state controlled by environmental cues and required for tissue physiology, as demonstrated for instance in the hematopoietic system [<xref rid="R22" ref-type="bibr">22</xref>]. As a consequence, much recent work has focused on the active regulation of this state [<xref rid="R23" ref-type="bibr">23</xref>]. Although the link between loss of quiescence and proliferation is intuitive, some observations obtained in the T cell model are intriguing. Indeed, one notable feature observed upon TCR stimulation is a comparatively long time period (&gt; 24 h) before the first cell division, as compared with the subsequent cell divisions that involve rapid doubling (every 5â6 hrs) [<xref rid="R24" ref-type="bibr">24</xref>]. The state through which naive T cells transit, from quiescence to the entry in the first cell cycle, is not fully characterized even if some metabolic events have been involved [<xref rid="R25" ref-type="bibr">25</xref>]. FAM65B was initially reported to be expressed in syncytia, both in placenta and in muscle [<xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R26" ref-type="bibr">26</xref>]. In syncytia, multinucleated cells result from cell-cell fusion induced by endogenous retroviral envelops [<xref rid="R27" ref-type="bibr">27</xref>, <xref rid="R28" ref-type="bibr">28</xref>]. Interestingly, it has recently been established that the cell-cell fusion induced by viruses led to cell cycle arrest and senescence, i.e. irreversible quiescence [<xref rid="R29" ref-type="bibr">29</xref>]. In addition, terminal differentiation of HL-60 cells led to both cell cycle arrest and FAM65B expression [<xref rid="R26" ref-type="bibr">26</xref>]. We now report that FAM65B is highly expressed in naive T lymphocytes, a cell population that is characterized by a reversible quiescent state, and is down-regulated upon cell cycle entry. The expression of FAM65B can therefore be considered as a molecular marker of quiescence, whether or not it can be reversed.</p>
      <p>FoxO1 is known to control cell proliferation through multiple mechanisms. FoxO factors stabilize G1 and G2/M checkpoints by the activation of a number of cell cycle regulatory proteins, including p130, members of the Cip/Kip and INK4 CKI families, cyclin G and Gadd45a. In addition, FoxO factors can also facilitate cell cycle arrest through the inhibition of the D-type cyclins and FoxM, a subgroup of Fox transcription factors that is known to positively drive G2/M phase transition [<xref rid="R30" ref-type="bibr">30</xref>]. In this study, we show that FAM65B, a transcriptional target of FOXO1, induces G2/M arrest. As previously proposed [<xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R18" ref-type="bibr">18</xref>], one mechanism to explain this effect might be an inhibition of the microtubule network by FAM65B, and especially a regulation of tubulin acetylation by FAM65B. Indeed, we know that FAM65B inhibits the deacetylase activity of HDAC6, a histone deacetylase of class II that functions as a tubulin deacetylase [<xref rid="R12" ref-type="bibr">12</xref>]. This hypothesis about a role of HDAC6 in the effects of FAM65B is further validated by our results showing that the cell cycle arrest induced by FAM65B can be overcome by an excess of HDAC6. It should also be noted that pharmacological inhibitors of HDAC6, which are used in clinical trials for the treatment of myeloma [<xref rid="R31" ref-type="bibr">31</xref>â<xref rid="R33" ref-type="bibr">33</xref>], mimic the anti-mitotic effect of FAM65B. In previous studies, HDAC6 activity was established as a requirement for efficient oncogenic transformation. Without HDAC6 expression, fibroblasts were more resistant to both Ras- and ErbB2-dependent transformations [<xref rid="R34" ref-type="bibr">34</xref>]. The absence of FAM65B expression in transformed cell lines, consecutive to the inhibition of FOXO1 transcriptional activity, might also participate in the deregulation of HDAC6 required for the transformation process. Thus, as observed in our experiments with transformed cells, the perturbed mitosis induced by FAM65B could be the result of a defective microtubule organization downstream of HDAC6, culminating in a failure of the mitotic spindle during mitosis. Interestingly, FAM65B was recently localized to the plasma membrane of the stereocilia of both inner and outer hair cells, and mutations of FAM65B leads to deafness syndromes, suggesting that the lack of functional FAM65B could hinder the development of the mechanotransduction apparatus, through perturbation of the primary cilium [<xref rid="R13" ref-type="bibr">13</xref>]. Indeed, HDAC6 has been notably implicated in cell proliferation <italic>via</italic> the regulation of the primary cilium [<xref rid="R35" ref-type="bibr">35</xref>, <xref rid="R36" ref-type="bibr">36</xref>], which is known to control the cell cycle [<xref rid="R37" ref-type="bibr">37</xref>].</p>
      <p>In addition, our work shows that the phosphorylation of FAM65B is required for both this anti-proliferative function and the formation of a tripartite complex comprised of FAM65B, 14.3.3 and HDAC6. Several studies have identified a possible phosphorylation of FAM65B not only in the Jurkat leukemic T cell line [<xref rid="R38" ref-type="bibr">38</xref>], but also in primary mouse neutrophils [<xref rid="R10" ref-type="bibr">10</xref>] and T lymphocytes [<xref rid="R39" ref-type="bibr">39</xref>]. In this latter case, the phosphorylation results from PKCÎ· activity [<xref rid="R39" ref-type="bibr">39</xref>]. The 14.3.3 scaffolding proteins play a critical role in the regulation of cell fate through phospho-dependent binding to a large number of intracellular proteins. This function can be achieved by the formation of multi-protein complexes upon recruitment of such proteins or by restricting the access of other ones [<xref rid="R14" ref-type="bibr">14</xref>]. FAM65B, as a well-known 14.3.3 phosphopeptide ligand, contains the consensus sequences RSXpT/SXP and RXY/FXpT/SXP. The study by Gao <italic>et al</italic>. [<xref rid="R10" ref-type="bibr">10</xref>], confirmed by our results, show that the phosphorylation of FAM65B allows its interaction with 14.3.3. Though it cannot be excluded that phosphorylated form of FAM65B directly interacts with HDAC6, the fact that the FAM65B/HDAC6 interaction has been observed only in the context where the three proteins were present and not detected in our yeast two-hybrid screen [<xref rid="R9" ref-type="bibr">9</xref>], suggests that 14.3.3 makes a link between HDAC6 and FAM65B.</p>
      <p>One intriguing feature of our work is the regulation of the T cell activation threshold by FAM65B. In T lymphocytes, the strength and duration of TCR signaling in response to antigen stimulation dictates the magnitude and the quality of the primary response [<xref rid="R40" ref-type="bibr">40</xref>, <xref rid="R41" ref-type="bibr">41</xref>]. The TCR activation threshold, agonist affinity discrimination as well as signal termination must therefore be tightly regulated. This is achieved through the concerted action of multiple positive and negative regulators acting in resting or activated T cells. The 14.3.3 scaffolding protein has already been involved in the fine tuning of TCR-activation through relocalization of several signaling proteins [<xref rid="R42" ref-type="bibr">42</xref>â<xref rid="R45" ref-type="bibr">45</xref>], including FoxO1 [<xref rid="R46" ref-type="bibr">46</xref>, <xref rid="R47" ref-type="bibr">47</xref>], suggesting a possible amplification loop that would keep FoxO1 in the cytosol and therefore would maintain FAM65B expression levels very low in activated T cells. Although much work will have to be done to precisely understand how FAM65B is able to set the activation threshold of T cells, it is tempting to assume, on the basis of our results, that its capacity to control the activity of the 14.3.3/HDAC6 complex could participate in this function.</p>
      <p>We have already shown that in T lymphocytes, FAM65B inhibits cell migration by blocking the GTP loading of RhoA [<xref rid="R9" ref-type="bibr">9</xref>]. Here, we show that FAM65B has a general quiescence promoting activity, which is active in resting T cells and controls both proliferation and setting of the activation threshold, at least in part through the 14.3.3/HDAC6 pathway. Therefore, in T cells, FAM65B appears as a main effector target of FOXO1 that is able to interact with two different targets to control the two main cellular processes of activation, i.e. migration and proliferation.</p>
    </sec>
    <sec sec-type="methods" id="s4">
      <title>MATERIALS AND METHODS</title>
      <sec id="s4_1">
        <title>Cells</title>
        <p>Human T lymphocytes were purified from the blood of healthy donors (Etablissement FranÃ§ais du Sang, Paris, France; relevant ethical approvals and consent have been obtained for use of human samples, ref E-2075) and cultivated as described [<xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R9" ref-type="bibr">9</xref>]. The naive (CD45RA+) and memory (CD45RO+) T cells were obtained by negative depletion on magnetic beads [Anti Human CD45RO Particles, Anti Human CD45RA Particles, respectively (BD Biosciences). Jurkat cells (gift of G. Crabtree, Stanford University, Stanford, CA) were cultivated in complete RPMI medium, HeLa (gift of C. Berlioz, Institut Cochin, France) and HEK293T cells (ATCC-CRL-3216) were cultivated in complete DMEM medium.</p>
      </sec>
      <sec id="s4_2">
        <title>Constructs and pharmacological inhibitors</title>
        <p>pEGFP-FAM65B plasmids were previously described [<xref rid="R9" ref-type="bibr">9</xref>]. Mutations of the RhoA interaction domain (RL151-152AA) and phosphorylation sites (S(x5)A) were constructed by PCR using QuickChange II site-directed mutagenesis Kit (Agilent) with the primers listed in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table S1</xref>. pmCherry-FAM65B was constructed by PCR by introducing the mCherry ORF at the <italic>Age</italic>I/<italic>Not</italic>I site of pEGFP-FAM65B. FAM65Bwt and S(x5)A Myc constructs were obtained by amplification with primers listed in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table S1</xref> and by introducing FAM65B ORF in pEF vector at the <italic>Spe</italic>I/<italic>EcoR</italic>V sites. plncx-Histone 2B-mCherry and plncx2-Tubuline-YFP were a kind gift of C. Berlioz (Institut Cochin, France) and pEGFP-N1-HDAC6 was purchased from Addgene (# 36188). HA-tagged 14.3.3 plasmid was a kind gift of JL Andersen (Brigham Young University, Provo, UT). HDAC6 specific antagonist CAY-10603 (Selleckchem) has been described and characterized before [<xref rid="R47" ref-type="bibr">47</xref>]. Etoposide is a kind gift of R. DonnÃ© (Institut Cochin, Paris). Î» Protein Phosphatase was from Millipore.</p>
      </sec>
      <sec id="s4_3">
        <title>Quantitative RT-PCR</title>
        <p>Total RNA was prepared using an RNeasy mini kit (QIAGEN). cDNA was produced with the Advantage RT-for-PCR kit (Clontech Laboratories) using 1 Î¼g total RNA and random hexamer priming in a final volume of 20 Î¼L. Real-time quantitative PCR was performed using the LightCycler FastStart DNA Master plus SYBR Green kit (Roche Diagnostics). Genes of interest were detected using primers that had been designed with Oligo6 software (Molecular Biology Insights) and optimized to generate a single amplicon of 80â130 nucleotides. The sequences of the primers used in qRT-PCR experiments are in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table S1</xref>.</p>
      </sec>
      <sec id="s4_4">
        <title>DNA and RNA interference transfections</title>
        <p>HeLa and HEK293T cells were transfected with Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions. Jurkat cells (5 Ã 10<sup>6</sup>) in 500 Î¼L of RPMI without phenol red were electroporated with 5 Î¼g DNA using the BioRad system (270 V, 950 Î¼F). Primary T cells (5 Ã 10<sup>6</sup>) were nucleofected using the Amaxa system (Lonza; kit T, U-014 program) with 5 Î¼g DNA or 2 Î¼L of a 100 Î¼M solution of OTP SMARTpool RNAi (Dharmacon) directed against human FAM65B or non-targeting sequences as a control.</p>
      </sec>
      <sec id="s4_5">
        <title>Flow cytometry</title>
        <p>Apoptosis was determined by staining with Annexin V-PE (BD Pharmingen, PE Annexin V Apoptosis Detection kit I) according to the manufacturer's instructions.</p>
        <p>Proliferation of primary T cells was assessed by dilution of Cell Trace Violet kit (Invitrogen). After two washes in PBS, cells were resuspended at 10<sup>6</sup> cells per mL in a 5 Î¼M Cell Trace Violet solution. Cells were incubated in dark at 37Â°C for 20 min. After the loading, cells were washed with a volume of cold PBS 10% FCS corresponding to 5 times the loading volume. Cell suspension was collected and dispensed into 96-well round-bottom microtiter plates (Falcon; 2 Ã 10<sup>5</sup> cells per well) and stimulated using anti-CD3/CD28 coated-beads (Dynabeads, Life technologies) for 3 days.</p>
        <p>For cell cycle analysis of transfected cells (Jurkat and HeLa cells), 10<sup>6</sup> cells were fixed with 4% paraformaldehyde for 10 min, permeabilized with 0,1% saponin, and incubated with PBS 1 mM EDTA Supplementary emented with 50 Î¼g/mL of Propidium Iodide (Sigma) and 200 Î¼g/mL of RNAse A (Sigma) for 30 min at 37Â°C.</p>
        <p>For analysis of ERK phosphorylation in transfected PBT, 10<sup>6</sup> cells were fixed with 4% paraformaldehyde for 10 min, permeabilized with methanol at â20Â°C for 1 hour, and incubated with anti-ERK<sup>P</sup> antibody (# 4370, Cell Signaling Technology) in PBS 0.2% BSA for 30 min at room temperature and then with F(ab')2-<italic>Goat anti-Rabbit</italic> IgG (H+L) secondary antibody (#A-21246, Thermofisher). Cytometry data were obtained using a BD-LSR Fortessa flow cytometer (BD Bioscience). Data files were analyzed using FlowJo software (TreeStar).</p>
      </sec>
      <sec id="s4_6">
        <title>Fluorescence microscopy</title>
        <p>Time-lapse microscopy was performed on HeLa cells grown on coverslips in a Zeiss Axiovert 200 microscope at 37Â°C with a 20Ã objective (LD Plan Neofluar). The camera CoolSnap HQ (Photometrics) was used to acquire images. Images were processed using ImageJ software.</p>
      </sec>
      <sec id="s4_7">
        <title>Biochemistry</title>
        <p>Primary T cells were stimulated using anti-CD3/CD28 -coated beads (1 bead per 5 cells, Dynabeads, Life technologies) into 96-well round-bottom microtiter plates (Falcon; 2 Ã 10<sup>5</sup> cells per well). Collected cells were lysed in lysis buffer [20 mM Bicine, pH7.6; 0.6% CHAPS complete protease and phosphatase inhibitor cocktail (Roche)] for 30 min on ice. Lysates were collected after centrifugation at 14,000 rpm for 10 min. Protein concentration in supernatants was quantified with the Bradford assay. SDS loading buffer was added to each sample and then boiled at 100Â°C for 5 min. An equal amount of proteins was loaded on 10% SDS-PAGE, transferred to nitrocellulose membranes, and immunoblotted with anti-FAM65B Ab (Abnova), anti-Î²-actin Ab (Sigma), anti-Î±-tubulin (Santa Cruz) or anti-eIF-4E (Santa Cruz) followed by a secondary HRP-labeled Ab (Jackson ImmunoResearch). Membranes were revealed by ECL (GE Healthcare Life Sciences) using a camera (Fusion FX7, VilberLourmat). For immunoprecipitation experiments, transfected cells were washed in cold PBS and lysed in 1 mL lysis buffer [10 mM HEPES pH 7.5; 150 mM KCl; 0.1%NP-40; 10 Î¼M SAHA (Sigma Aldrich); 40 Î¼M Tubacin (Sigma Aldrich); 50 Î¼M Nicotinamide (Sigma Aldrich); complete protease and phosphatase inhibitor cocktails (Roche)] for 30 min in ice. Lysates were collected after centrifugation at 14,000 rpm for 10 min. 40 Î¼L of each lysate was saved and used as a loading control. 20 Î¼L of EZ myc beads (Sigma Aldrich) pre-washed 3 times with lysis buffer were added in the lysate and rotated for 2 h at 4Â°C. After rotating, the beads were washed 3 times with lysis buffer and resuspended into 100 Î¼L of TBS1X containing 10 Î¼g/mL of myc peptide for 30 min at 4Â°C. 70 Î¼L of the supernatant containing the protein complexes without beads/Ab was taken off. Each sample was boiled at 100Â°C for 5 min after adding 5Ã Laemmli buffer, subjected to 12% SDS-PAGE, transferred to nitrocellulose membrane and immunoblotted with the indicated antibodies. Pull-down assays with beads containing GST-tagged RhoA (Cytoskeleton) were described in Rougerie <italic>et al.</italic> [<xref rid="R9" ref-type="bibr">9</xref>].</p>
      </sec>
      <sec id="s4_8">
        <title>Statistical analysis</title>
        <p>Statistical significance was analyzed by paired two-tailed Student's <italic>t</italic>-test and expressed as a <italic>p</italic> value. The number of analyzed samples (n) is indicated. All experiments were performed at least as three independent experiments. When indicated, standard deviations are represented as scale bars on graphs. We used the following conventions to illustrate the <italic>p</italic> value: *0.01 &lt; <italic>p</italic> &lt; 0.05, **0.01 &lt; <italic>p</italic> &lt; 0.001, ***<italic>p</italic> &lt; 0.001. ns: not significant.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material" id="s5">
      <title>SUPPLEMENTARY MATERIALS FIGURES AND TABLES</title>
      <supplementary-material content-type="local-data" id="SD1">
        <media mimetype="application" mime-subtype="pdf" xlink:href="oncotarget-07-63215-s001.pdf" orientation="portrait" xlink:type="simple" id="d35e968" position="anchor"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank E. Gussoni for providing reagents. C. Randriamampita and C. Charvet for discussions and N. Delon for editing the manuscript. This work was supported by Inserm, CNRS and Ligue Nationale Contre le Cancer. Cytometry data acquisition, cell sorting and time-lapse experiments were performed in the Immunobiology and Imaging Cochin facilities, respectively.</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>
          <bold>CONFLICTS OF INTEREST</bold>
        </p>
        <p>The authors declare that they have no conflicts of interest.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>
          <bold>FUNDING SUPPORT</bold>
        </p>
        <p>This work was granted by La Ligue Nationale Contre le Cancer, CNRS and Inserm.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yusuf</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fruman</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Regulation of quiescence in lymphocytes</article-title>
          <source>Trends Immunol</source>
          <year>2003</year>
          <volume>24</volume>
          <fpage>380</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="pmid">12860529</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Surh</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Sprent</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Homeostasis of naive and memory T cells</article-title>
          <source>Immunity</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>848</fpage>
          <lpage>862</lpage>
          <pub-id pub-id-type="pmid">19100699</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takada</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jameson</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Naive T cell homeostasis: from awareness of space to a sense of place</article-title>
          <source>Nat Rev Immunol</source>
          <year>2009</year>
          <volume>9</volume>
          <fpage>823</fpage>
          <lpage>832</lpage>
          <pub-id pub-id-type="pmid">19935802</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eijkelenboom</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Burgering</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>FOXOs: signalling integrators for homeostasis maintenance</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2013</year>
          <volume>14</volume>
          <fpage>83</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">23325358</pub-id>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Webb</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Brunet</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>FOXO transcription factors: key regulators of cellular quality control</article-title>
          <source>Trends Biochem Sci</source>
          <year>2014</year>
          <volume>39</volume>
          <fpage>159</fpage>
          <lpage>169</lpage>
          <pub-id pub-id-type="pmid">24630600</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fabre</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Harriague</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jobart</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Unterman</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Trautmann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bismuth</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Stable activation of phosphatidylinositol 3-kinase in the T cell immunological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control</article-title>
          <source>J Immunol</source>
          <year>2005</year>
          <volume>174</volume>
          <fpage>4161</fpage>
          <lpage>4171</lpage>
          <pub-id pub-id-type="pmid">15778376</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fabre</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Carrette</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Semichon</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Denoyelle</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lazar</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Cagnard</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Dubart-Kupperschmitt</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mangeney</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fruman</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Bismuth</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase</article-title>
          <source>J Immunol</source>
          <year>2008</year>
          <volume>181</volume>
          <fpage>2980</fpage>
          <lpage>2989</lpage>
          <pub-id pub-id-type="pmid">18713968</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kerdiles</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Beisner</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Tinoco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dejean</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Castrillon</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>DePinho</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Hedrick</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Foxo1 links homing and survival of naive T cells by regulating L-selectin CCR7 and interleukin 7 receptor</article-title>
          <source>Nat Immunol</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>176</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="pmid">19136962</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rougerie</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Largeteau</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Megrelis</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Carrette</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lejeune</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Toffali</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zeghouf</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cherfils</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Constantin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Laudanna</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bismuth</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mangeney</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fam65b is a new transcriptional target of FOXO1 that regulates RhoA signaling for T lymphocyte migration</article-title>
          <source>J Immunol</source>
          <year>2013</year>
          <volume>190</volume>
          <fpage>748</fpage>
          <lpage>755</lpage>
          <pub-id pub-id-type="pmid">23241886</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gao</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Front-signal-dependent accumulation of the RHOA inhibitor FAM65B at leading edges polarizes neutrophils</article-title>
          <source>J Cell Sci</source>
          <year>2015</year>
          <volume>128</volume>
          <fpage>992</fpage>
          <lpage>1000</lpage>
          <pub-id pub-id-type="pmid">25588844</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoon</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Molloy</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Cowan</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Gussoni</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>C6ORF32 is upregulated during muscle cell differentiation and induces the formation of cellular filopodia</article-title>
          <source>Dev Biol</source>
          <year>2007</year>
          <volume>301</volume>
          <fpage>70</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">17150207</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balasubramanian</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kawahara</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Rozkalne</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Beauvais</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kunkel</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Gussoni</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation</article-title>
          <source>Faseb J</source>
          <year>2014</year>
          <volume>28</volume>
          <fpage>2955</fpage>
          <lpage>2969</lpage>
          <pub-id pub-id-type="pmid">24687993</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diaz-Horta</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Subasioglu-Uzak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grati</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>DeSmidt</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Foster</surname>
              <given-names>J</given-names>
              <suffix>2nd</suffix>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bademci</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tokgoz-Yilmaz</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Duman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cengiz</surname>
              <given-names>FB</given-names>
            </name>
            <name>
              <surname>Abad</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mittal</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2014</year>
          <volume>111</volume>
          <fpage>9864</fpage>
          <lpage>9868</lpage>
          <pub-id pub-id-type="pmid">24958875</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gardino</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Yaffe</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>14-3-3 proteins as signaling integration points for cell cycle control and apoptosis</article-title>
          <source>Semin Cell Dev Biol</source>
          <year>2011</year>
          <volume>22</volume>
          <fpage>688</fpage>
          <lpage>695</lpage>
          <pub-id pub-id-type="pmid">21945648</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>FD</given-names>
            </name>
            <name>
              <surname>Stark</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wells</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Fawcett</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Kulkarni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Metalnikov</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>O'Donnell</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zougman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Woodgett</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Langeberg</surname>
              <given-names>LK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proteomic functional and domain-based analysis of <italic>in vivo</italic> 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization</article-title>
          <source>Curr Biol</source>
          <year>2004</year>
          <volume>14</volume>
          <fpage>1436</fpage>
          <lpage>1450</lpage>
          <pub-id pub-id-type="pmid">15324660</pub-id>
        </element-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuzaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Daitoku</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hatta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fukamizu</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2003</year>
          <volume>100</volume>
          <fpage>11285</fpage>
          <lpage>11290</lpage>
          <pub-id pub-id-type="pmid">13679577</pub-id>
        </element-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Connell</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Khodjakov</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>Cooperative mechanisms of mitotic spindle formation</article-title>
          <source>J Cell Sci</source>
          <year>2007</year>
          <volume>120</volume>
          <fpage>1717</fpage>
          <lpage>1722</lpage>
          <pub-id pub-id-type="pmid">17502482</pub-id>
        </element-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirayama</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Identification and characterization of a novel neural cell adhesion molecule (NCAM)-associated protein from quail myoblasts: relationship to myotube formation and induction of neurite-like protrusions</article-title>
          <source>Differentiation</source>
          <year>2008</year>
          <volume>76</volume>
          <fpage>253</fpage>
          <lpage>266</lpage>
          <pub-id pub-id-type="pmid">17825087</pub-id>
        </element-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chircop</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Rho GTPases as regulators of mitosis and cytokinesis in mammalian cells</article-title>
          <source>Small GTPases</source>
          <year>2014</year>
          <fpage>5</fpage>
        </element-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mortenson</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Heppler</surname>
              <given-names>LN</given-names>
            </name>
            <name>
              <surname>Banks</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Weerasekara</surname>
              <given-names>VK</given-names>
            </name>
            <name>
              <surname>Whited</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Piccolo</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Histone deacetylase 6 (HDAC6) promotes the pro-survival activity of 14-3-3zeta via deacetylation of lysines within the 14-3-3zeta binding pocket</article-title>
          <source>J Biol Chem</source>
          <year>2015</year>
          <volume>290</volume>
          <fpage>12487</fpage>
          <lpage>12496</lpage>
          <pub-id pub-id-type="pmid">25770209</pub-id>
        </element-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akbar</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Vukmanovic-Stejic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Taams</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Macallan</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
          <article-title>The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery</article-title>
          <source>Nat Rev Immunol</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>231</fpage>
          <lpage>237</lpage>
          <pub-id pub-id-type="pmid">17318234</pub-id>
        </element-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsu</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Fuchs</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>A family business: stem cell progeny join the niche to regulate homeostasis</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>103</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="pmid">22266760</pub-id>
        </element-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheung</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Rando</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>Molecular regulation of stem cell quiescence</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2013</year>
          <volume>14</volume>
          <fpage>329</fpage>
          <lpage>340</lpage>
          <pub-id pub-id-type="pmid">23698583</pub-id>
        </element-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rowell</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Wells</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>The role of cyclin-dependent kinases in T-cell development proliferation and function</article-title>
          <source>Crit Rev Immunol</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>189</fpage>
          <lpage>212</lpage>
          <pub-id pub-id-type="pmid">16928186</pub-id>
        </element-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shrestha</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Karmaus</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Neale</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Guertin</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Lamb</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Chi</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming</article-title>
          <source>Immunity</source>
          <year>2013</year>
          <volume>39</volume>
          <fpage>1043</fpage>
          <lpage>1056</lpage>
          <pub-id pub-id-type="pmid">24315998</pub-id>
        </element-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dakour</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Morrish</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>PL48: a novel gene associated with cytotrophoblast and lineage-specific HL-60 cell differentiation</article-title>
          <source>Gene</source>
          <year>1997</year>
          <volume>185</volume>
          <fpage>153</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="pmid">9055809</pub-id>
        </element-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blaise</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>de Parseval</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Benit</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Heidmann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2 a gene conserved on primate evolution</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2003</year>
          <volume>100</volume>
          <fpage>13013</fpage>
          <lpage>13018</lpage>
          <pub-id pub-id-type="pmid">14557543</pub-id>
        </element-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Veldman</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Finnerty</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Racie</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>LaVallie</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>XY</given-names>
            </name>
            <name>
              <surname>Edouard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Howes</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Keith</surname>
              <given-names>JC</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>McCoy</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis</article-title>
          <source>Nature</source>
          <year>2000</year>
          <volume>403</volume>
          <fpage>785</fpage>
          <lpage>789</lpage>
          <pub-id pub-id-type="pmid">10693809</pub-id>
        </element-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chuprin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gal</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Biron-Shental</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Biran</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Amiel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rozenblatt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Krizhanovsky</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Cell fusion induced by ERVWE1 or measles virus causes cellular senescence</article-title>
          <source>Genes Dev</source>
          <year>2013</year>
          <volume>27</volume>
          <fpage>2356</fpage>
          <lpage>2366</lpage>
          <pub-id pub-id-type="pmid">24186980</pub-id>
        </element-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ho</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Myatt</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>EW</given-names>
            </name>
          </person-group>
          <article-title>Many forks in the path: cycling with FoxO</article-title>
          <source>Oncogene</source>
          <year>2008</year>
          <volume>27</volume>
          <fpage>2300</fpage>
          <lpage>2311</lpage>
          <pub-id pub-id-type="pmid">18391972</pub-id>
        </element-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aldana-Masangkay</surname>
              <given-names>GI</given-names>
            </name>
            <name>
              <surname>Rodriguez-Gonzalez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>YT</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Lomenick</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Okemoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Landaw</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mazitschek</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bradner</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Sakamoto</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells</article-title>
          <source>Leuk Lymphoma</source>
          <year>2011</year>
          <volume>52</volume>
          <fpage>1544</fpage>
          <lpage>1555</lpage>
          <pub-id pub-id-type="pmid">21699378</pub-id>
        </element-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hackanson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rimmele</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Benkisser</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Abdelkarim</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fliegauf</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lubbert</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>HDAC6 as a target for antileukemic drugs in acute myeloid leukemia</article-title>
          <source>Leuk Res</source>
          <year>2012</year>
          <volume>36</volume>
          <fpage>1055</fpage>
          <lpage>1062</lpage>
          <pub-id pub-id-type="pmid">22464548</pub-id>
        </element-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsuji</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Okiyama</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Villarroel</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>SI</given-names>
            </name>
          </person-group>
          <article-title>Histone deacetylase 6 inhibition impairs effector CD8 T-cell functions during skin inflammation</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>2015</year>
          <volume>135</volume>
          <fpage>1228</fpage>
          <lpage>1239</lpage>
          <pub-id pub-id-type="pmid">25458911</pub-id>
        </element-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Laurent</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bause</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Spang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>German</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Haigis</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Haigis</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS</article-title>
          <source>Mol Cancer Res</source>
          <year>2013</year>
          <volume>11</volume>
          <fpage>1072</fpage>
          <lpage>1077</lpage>
          <pub-id pub-id-type="pmid">23723075</pub-id>
        </element-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forcioli-Conti</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Esteve</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bouloumie</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dani</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Peraldi</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The size of the primary cilium and acetylated tubulin are modulated during adipocyte differentiation: Analysis of HDAC6 functions in these processes</article-title>
          <source>Biochimie</source>
          <year>2015</year>
          <volume>124</volume>
          <fpage>112</fpage>
          <lpage>123</lpage>
          <pub-id pub-id-type="pmid">26363102</pub-id>
        </element-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gradilone</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Radtke</surname>
              <given-names>BN</given-names>
            </name>
            <name>
              <surname>Bogert</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>BQ</given-names>
            </name>
            <name>
              <surname>Gajdos</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>LaRusso</surname>
              <given-names>NF</given-names>
            </name>
          </person-group>
          <article-title>HDAC6 inhibition restores ciliary expression and decreases tumor growth</article-title>
          <source>Cancer Res</source>
          <year>2013</year>
          <volume>73</volume>
          <fpage>2259</fpage>
          <lpage>2270</lpage>
          <pub-id pub-id-type="pmid">23370327</pub-id>
        </element-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ishikawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>WF</given-names>
            </name>
          </person-group>
          <article-title>Ciliogenesis: building the cellâs antenna</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>222</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="pmid">21427764</pub-id>
        </element-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayya</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lundgren</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Rezaul</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Eng</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Rodionov</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>DK</given-names>
            </name>
          </person-group>
          <article-title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions</article-title>
          <source>Sci Signal</source>
          <year>2009</year>
          <volume>2</volume>
          <fpage>ra46</fpage>
          <pub-id pub-id-type="pmid">19690332</pub-id>
        </element-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kong</surname>
              <given-names>KF</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yokosuka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Casas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Canonigo-Balancio</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Becart</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Yates</surname>
              <given-names>JR</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Kronenberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gascoigne</surname>
              <given-names>NR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Protein kinase C-eta controls CTLA-4-mediated regulatory T cell function</article-title>
          <source>Nat Immunol</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>465</fpage>
          <lpage>472</lpage>
          <pub-id pub-id-type="pmid">24705298</pub-id>
        </element-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chakraborty</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Insights into the initiation of TCR signaling</article-title>
          <source>Nat Immunol</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>798</fpage>
          <lpage>807</lpage>
          <pub-id pub-id-type="pmid">25137454</pub-id>
        </element-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith-Garvin</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Koretzky</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>T cell activation</article-title>
          <source>Annu Rev Immunol</source>
          <year>2009</year>
          <volume>27</volume>
          <fpage>591</fpage>
          <lpage>619</lpage>
          <pub-id pub-id-type="pmid">19132916</pub-id>
        </element-citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonnefoy-Berard</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>von Willebrand</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Elly</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mustelin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ishizaka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Altman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1995</year>
          <volume>92</volume>
          <fpage>10142</fpage>
          <lpage>10146</lpage>
          <pub-id pub-id-type="pmid">7479742</pub-id>
        </element-citation>
      </ref>
      <ref id="R43">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foucault</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Bernard</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Deckert</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The chaperone protein 14-3-3 interacts with 3BP2/SH3BP2 and regulates its adapter function</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>7146</fpage>
          <lpage>7153</lpage>
          <pub-id pub-id-type="pmid">12501243</pub-id>
        </element-citation>
      </ref>
      <ref id="R44">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Elly</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bonnefoy-Berard</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Altman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Activation-modulated association of 14-3-3 proteins with Cbl in T cells</article-title>
          <source>J Biol Chem</source>
          <year>1996</year>
          <volume>271</volume>
          <fpage>14591</fpage>
          <lpage>14595</lpage>
          <pub-id pub-id-type="pmid">8663231</pub-id>
        </element-citation>
      </ref>
      <ref id="R45">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meller</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Bonnefoy-Berard</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Baier</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Isakov</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Altman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function</article-title>
          <source>Mol Cell Biol</source>
          <year>1996</year>
          <volume>16</volume>
          <fpage>5782</fpage>
          <lpage>5791</lpage>
          <pub-id pub-id-type="pmid">8816492</pub-id>
        </element-citation>
      </ref>
      <ref id="R46">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oh</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Dambuza</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Marrero</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Egwuagu</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>STAT3 protein interacts with Class O Forkhead transcription factors in the cytoplasm and regulates nuclear/cytoplasmic localization of FoxO1 and FoxO3a proteins in CD4(+) T cells</article-title>
          <source>J Biol Chem</source>
          <year>2012</year>
          <volume>287</volume>
          <fpage>30436</fpage>
          <lpage>30443</lpage>
          <pub-id pub-id-type="pmid">22761423</pub-id>
        </element-citation>
      </ref>
      <ref id="R47">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dhanyamraju</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Holz</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Finkernagel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fendrich</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lauth</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Histone deacetylase 6 represents a novel drug target in the oncogenic Hedgehog signaling pathway</article-title>
          <source>Mol Cancer Ther</source>
          <year>2015</year>
          <volume>14</volume>
          <fpage>727</fpage>
          <lpage>739</lpage>
          <pub-id pub-id-type="pmid">25552369</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>